Clinical Trials

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Two acquisitions add a phase 3 oral Stargardt asset and a post-injection antiseptic. The work now shifts to trial operations, CMC, and future specialty distribu

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's July 2026 white paper offers a practical framework for validating digital endpoints in CNS trials, covering sensors, software, and connected devices.

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Evolving Biomarkers: Charting the Future of Precision Medicine

The shift from broad treatments to targeted therapies hinges on identifying which patients will actually benefit from specific drugs

Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

Smaller pharma companies are accelerating drug development by leveraging advanced data analytics to streamline trials and regulatory pathways